According to the NCCN guidelines, AT can be used to treat the following cancer-related symptoms: neuropathic pain, arthralgia, myalgia (especially in aromatase inhibitor therapy), nausea, vomiting and fatigue [48]. The gene discussed is CYP19A1; the disease is cancer.